Showing 109 news articles about PrEP science

Filters Content type: Editors' picks Topic: PrEP science

Research, news and information on the effectiveness of oral pre-exposure prophylaxis (PrEP) and its impact on HIV epidemics, as well as clinical issues for PrEP users.

PrEP science

Islatravir Subdermal Implant for HIV PrEP Has Promising Phase 1 Trial

Editor's pick
Contagion Live
7 October 2021
PrEP science

First-in-Class NRTTI Demonstrates Potential as Long-Acting Oral PrEP Against HIV

Editor's pick
Contagion Live
13 September 2021
PrEP science

Truvada or Descovy for PrEP? Your Lab Work May Tell You

Editor's pick
POZ
8 September 2021
Resistance

Transmitted Drug Resistance to Tenofovir and Emtricitabine is declining in China

Editor's pick
Infectious Disease Advisor
12 August 2021
PrEP science

Two PrEP medications are now available. Equally safe/effective. The biggest difference? The price tag.

Editor's pick
Medical Xpress
5 August 2021
Coronavirus

PrEP Study Sees No Link Between Tenofovir and COVID-19

Editor's pick
POZ
28 July 2021
Injectable & long-acting PrEP

IAS: Merck's long-acting HIV med hits protective levels in phase 2

Editor's pick
FierceBiotech
21 July 2021
PrEP science

Continuing declines in HIV diagnoses thanks to successful PrEP roll-out in New South Wales

Editor's pick
University of New South Wales
2 July 2021
HIV prevention policy

The future of antibody-based HIV prevention

Editor's pick
IAVI
10 May 2021
PrEP science

As CROI 2021 Attests, the PrEP Revolution Is Coming

Editor's pick
TheBodyPro
6 April 2021
PrEP science

Low New-HIV Rate With Both Daily and On-Demand PrEP in Paris MSM

Editor's pick
NATAP
17 March 2021
PrEP science

A pill, a ring or a jab: The future of HIV prevention is choice

Editor's pick
Bhekisisa
4 February 2021
Vaginal rings & topical PrEP

Biodegradable TAF Implants Protect 6 of 6 Macaques From Vaginal SHIV

Editor's pick
NATAP
2 February 2021
PrEP science

Periodic PrEP – a new way to take PrEP

Editor's pick
Ending HIV
14 January 2021
PrEP science

The link between vaginal bacteria and PrEP effectiveness

Editor's pick
Avert
22 December 2020
PrEP science

How the vaginal microbiome may affect HIV prevention

Editor's pick
EurekAlert
4 December 2020
HIV treatment

Top 10 HIV Clinical Developments of 2020

Editor's pick
TheBodyPro
1 December 2020
Injectable & long-acting PrEP

Trial results reveal that long-acting injectable cabotegravir as PrEP is highly effective in preventing HIV acquisition in women

Editor's pick
World Health Organization
10 November 2020
Pharmaceutical industry

GlaxoSmithKline's HIV PrEP challenge looms as ViiV's long-acting drug tops Gilead's Truvada in women

Editor's pick
FiercePharma
10 November 2020
Injectable & long-acting PrEP

ViiV Healthcare announces investigational injectable cabotegravir is superior to oral standard of care for HIV prevention in women

Editor's pick
ViiV press release
9 November 2020
PrEP programmes & uptake

Shared Decision-Making Aids Choice of PrEP

Editor's pick
Medscape (requires free registration)
29 October 2020
PrEP science

Q&A: What clinicians should know about starting, stopping and restarting PrEP

Editor's pick
Healio
14 September 2020
Clinical trials

Designing a New Generation of HIV Prevention Efficacy Trials

Editor's pick
AVAC
23 August 2020
Adherence

Novel Immunoassay Demonstrates Predictive Utility in PrEP Adherence, HIV Protection

Editor's pick
Infectious Disease Advisor
28 July 2020